ID: ALA4542017

Max Phase: Preclinical

Molecular Formula: C21H23F3N4S

Molecular Weight: 420.50

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  FC(F)(F)Cc1cc2c(NCC3CCN(Cc4ccccc4)CC3)ncnc2s1

Standard InChI:  InChI=1S/C21H23F3N4S/c22-21(23,24)11-17-10-18-19(26-14-27-20(18)29-17)25-12-15-6-8-28(9-7-15)13-16-4-2-1-3-5-16/h1-5,10,14-15H,6-9,11-13H2,(H,25,26,27)

Standard InChI Key:  WOXHQCHYDTWCMH-UHFFFAOYSA-N

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MEN1 Tchem Menin/Histone-lysine N-methyltransferase MLL (48157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 420.50Molecular Weight (Monoisotopic): 420.1596AlogP: 5.12#Rotatable Bonds: 6
Polar Surface Area: 41.05Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.19CX LogP: 4.85CX LogD: 3.06
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -1.68

References

1. Ren J, Xu W, Tang L, Su M, Chen D, Chen YL, Zang Y, Li J, Shen J, Zhou Y, Xiong B..  (2016)  Design and synthesis of benzylpiperidine inhibitors targeting the menin-MLL1 interface.,  26  (18): [PMID:27528435] [10.1016/j.bmcl.2016.07.074]

Source